Ecolab reported an 11% increase in adjusted EPS for Q2 2026, driven by 5% organic sales growth. Pricing strengthened to 4% in the quarter, with expectations of 5% to 6% in the second half. Life Sciences delivered strong performance with 15% growth and a mid-20% operating income margin. Global High-Tech surged 29%, approaching $1.5 billion in annualised sales, supported by the CoolIT Systems acquisition. Ecolab Digital grew 27%. The company faced challenges including a nearly 1% volume headwind from Middle East disruptions and low single-digit declines in underperforming businesses representing 15% of sales. Ecolab raised its 2026 EPS outlook to $8.05 to $8.25, representing 7% to 10% growth versus last year. The company expects 6% to 7% organic sales growth in the second half and reaffirmed its 20% operating margin target for 2027.

Ecolab reported second quarter 2026 results showing reported sales of $4.4 billion, up 10%, with organic sales growth accelerating to 5%. The company posted reported diluted earnings per share of $1.90, up 3%, and adjusted diluted EPS of $2.09, representing 11% growth. The St Paul-based water and hygiene solutions provider raised its full-year 2026 adjusted diluted EPS outlook to a range of $8.05 to $8.25, representing 7% to 10% growth. This exceeded prior expectations of $8.03 to $8.23. Growth was driven by strong volume increases despite Middle East disruptions, improved pricing and productivity gains that offset rising commodity costs. The company's reported operating income margin reached 17.2%, whilst organic operating income margin stood at 18.8%, up 40 basis points. Ecolab expects third quarter 2026 adjusted diluted EPS between $2.13 and $2.23, representing 3% to 8% growth.

Ecolab Q2 earnings call highlights. July 28, 2026 Key points. * Ecolab raised its full-year 2026 adjusted EPS outlook to $8.05-$8.25, representing 7%-10% growth, after reporting 11% adjusted EPS growth and 5% organic sales growth in the second quarter. * Growth was led by Life Sciences, Ecolab Digital, Pest Elimination and Global High-Tech, with Global High-Tech sales rising 29% amid demand from data centers and artificial-intelligence infrastructure. The company expects its expanded platform, including CoolIT and Ovivo, to reach $4 billion in sales by 2030. * Ecolab expects second-half organic sales growth of 6%-7% and pricing growth of 5%-6% as energy surcharges take full effect, supporting its target of reaching a 20% operating-income margin in 2027. * MarketBeat previews the top five stocks to own by August 1st. Ecolab NYSE: ECL reported second-quarter 2026 adjusted earnings-per-share growth of 11%, supported by 5% organic sales growth, stable organic gross margin and productivity gains, Chairman and Chief Executive Officer Christophe Beck said on the company's earnings call. The company said pricing strengthened to 4% during the quarter as it implemented a global energy surcharge intended to offset higher commodity costs. Ecolab entered the period with limited surcharge pricing and expected the benefit to build during the quarter. Beck said the company now expects pricing in the 5% to 6% range during the second half as surcharge benefits are fully realized. Volumes increased 1%, despite what Ecolab described as an approximately 1% headwind from customer operations disrupted by conflict in the Middle East. Excluding that impact, Beck said underlying volume growth accelerated from the first quarter. Growth engines lead portfolio momentum. Ecolab said its Food and Beverage business accelerated to 7% growth, while Institutional & Specialty grew 4% and Light Water improved. The company attributed growth in part to new business from its One Ecolab Growth initiative, which combines capabilities across businesses to expand cross-selling opportunities. Among its growth engines, Life Sciences grew 15%, driven by share gains in bioprocessing, pharmaceutical and personal-care markets, as well as improved purification performance. Beck said Life Sciences delivered a mid-20% operating-income margin in the second quarter, aided by strong sales and a spike in bioprocessing. He added that underlying margins should remain in the mid-20% range, although reported third-quarter margin is expected in the high teens as the company continues investing in capacity and capabilities. The Life Sciences business has grown from less than $100 million in 2017 to nearly $1 billion currently, according to Beck. He said Ecolab has expanded production capacity across North America, Europe and Asia, including the opening of a major plant in China. The company continues to target a roughly 30% operating-income margin for the business at scale, while emphasizing continued investment ahead of growth. Discover more Derivatives Options Profit Calculator Dividend Screener Tool Ecolab Digital grew 27% in the quarter, reflecting adoption of connected software and operational tools including DishIQ, AquaIQ, KitchenIQ and CIP IQ. Beck said the digital business is approaching a $500 million annual revenue run rate and has a potential $3 billion revenue opportunity from connecting customer locations and applications and generating subscription revenue from those offerings. Pest Elimination grew 7%, supported by share gains and expansion of its Pest Intelligence platform. Ecolab said it has deployed nearly 800,000 connected devices and expects to exceed 1 million by year-end. High-Tech business expands with CoolIT. Global High-Tech sales grew 29% as demand rose in microelectronics and data centers amid the buildout of artificial-intelligence infrastructure. Ecolab completed its acquisition of liquid-cooling provider CoolIT Systems on July 2. Beck said CoolIT's year-to-date sales growth before the acquisition exceeded 100%. Ecolab's Global High-Tech platform is approaching $1.5 billion in annualized sales, consisting of roughly $500 million each from its legacy high-tech operations, CoolIT and Ovivo, Beck said. The company expects the combined Global High-Tech platform to grow more than 25% annually and reach $4 billion in sales by 2030, with a 25% operating-income margin. Those targets were raised from previous expectations for more than 20% growth and a 20% margin. On a pro forma basis including Ovivo and CoolIT, Ecolab said company sales growth would have been about 7% in the second quarter, with the acquired businesses adding roughly two percentage points of growth. Beck said Ecolab plans to introduce an integrated cooling platform at the Supercomputing conference that combines CoolIT's liquid-cooling technology with Ecolab's 3D TRASAR digital capabilities. The company will hold an investor day at the Supercomputing conference in Chicago on Nov. 17, when it expects to provide further detail on Global High-Tech's outlook. Beck said Ecolab is still early in integrating CoolIT and continues to use a 30% long-term growth assumption for the acquired business. Margins, investment and outlook. Ecolab expects organic sales growth of 6% to 7% in the second half, with adjusted operating-income margin of 19%. The company said that trajectory keeps it on track to achieve a 20% operating-income margin next year. Chief Financial Officer Scott Kirkland said Ecolab expects commodity costs to remain at high-single-digit levels for the balance of 2026. He also noted that Ovivo reduced reported gross margin by about 60 basis points in the second quarter, while Ecolab's organic gross margin excluding Ovivo was stable. The company expects capital expenditures to remain around 7% of sales over the next several years as it invests ahead of growth in Global High-Tech and Life Sciences, Kirkland said. He added that Ecolab remains focused on increasing organic return on invested capital by at least 100 basis points annually and expects to return to pre-CoolIT acquisition organic ROIC levels by 2028. Ecolab raised its full-year 2026 adjusted EPS outlook to a range of $8.05 to $8.25, representing growth of 7% to 10% from the prior year. The forecast includes the near-term effects of non-cash amortization and financing costs associated with the CoolIT acquisition. Beyond 2026, Beck said the company continues to expect adjusted EPS growth, including CoolIT, to accelerate to a 12% to 15% trajectory. About Ecolab (NYSE:ECL). Ecolab, Inc is a global provider of water, hygiene and infection prevention solutions and services. The company develops and supplies cleaning and sanitizing chemicals, dispensing equipment, water-treatment systems, pest elimination services and related technologies designed to help businesses maintain clean, safe and efficient operations. Its offerings span both products and onsite services, often paired with technical support and training. Ecolab serves a broad range of end markets including hospitality and foodservice, food and beverage processing, healthcare, manufacturing and industrial operations, and energy and utilities. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Ecolab, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ecolab wasn't on the list. While Ecolab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge - and the key risks investors should watch as the global AI buildout accelerates.